This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: Resistance to numerous insecticide classes in Bemisia tabaci Gennadius has impaired field control efficacy in south-eastern China. The biotype and resistance status of B. tabaci collected from these areas was investigated. RESULTS: Two different biotypes of B. tabaci (B-biotype and Q-biotype) were detected in south-eastern China, and the samples collected from geographical regions showed a prevalence of the Q-biotype and the coexistence of B- and Q-biotypes in some regions. Moderate to high levels of resistance to two neonicotinoids were established in both biotypes (28-1900-fold to imidacloprid, 29-1200-fold to thiamethoxam). Medium to high levels of resistance to alpha-cypermethrin (22-610-fold) were also detected in both biotypes. Four out of 12 populations had low to medium levels of resistance to fipronil (10-25-fold). Four out of 12 populations showed low levels of resistance to spinosad (5.7-6.4-fold). All populations tested were susceptible to abamectin. CONCLUSION: The Q-biotype B. tabaci is supplanting the B-biotype which used to be ubiquitous in China. Field populations of both B- and Q-biotypes of B. tabaci have developed high levels of resistance to imidacloprid and thiamethoxam. Abamectin is the most effective insecticide against adult B. tabaci from all populations.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: